Dermatology News & Articles

1 Migraine, triptans, and the risk of developing rosacea: A population-based study within the United Kingdom Journal of the American Academy of Dermatology, May 7, 2013
Spoendlin J et al. - The authors sought to analyze the association between migraine or triptan exposure and the risk of developing rosacea within the United Kingdom. They observed a slightly increased risk for female migraineurs to develop rosacea, particularly in women with severe migraine aged 50 years or older.

2 Pediatricians Endorse New Acne Treatment Guidelines HealthDay, May 7, 2013
Experts note many medications now available for range of cases. Pimples have long been the bane of teenage existence, but pediatricians say there is now enough evidence on effective treatments to put out the first guidelines on battling acne in children. There is a range of medications that can clear up even severe cases of acne, according to the American Academy of Pediatrics (AAP). Writing in the May issue of its journal Pediatrics, the group throws its support behind new guidelines from the ...

3 Minocycline-Induced Scleral and Dermal Pigmentation JAMA Ophthalmology, May 16, 2013
Kovach JL et al. - Photographs showing bluish pigmentation of bilateral sclera within the palpebral fissure in both the right eye and the left eye of a 65-year-old white man who developed scleral and skin pigmentation after 30 years of using minocycline hydrochloride for the treatment of ocular rosacea. Dermal pigmentation can also be seen on the left medial malleolus.

4 Comparative effectiveness of nonpurpuragenic 595-nm pulsed dye laser and microsecond 1064-nm neodymium:yttrium-aluminum-garnet laser for treatment of diffuse facial erythema: A double-blind randomized controlled trial Journal of the American Academy of Dermatology, May 21, 2013
Alam M et al. - Facial erythema is a common symptom that responds to vascular laser treatment, but there are few comparative studies. Facial erythema is safely and effectively treated with PDL and Nd:YAG. Nonpupuragenic PDL may be more effective for lighter-skinned patients, but microsecond Nd:YAG may be less painful.